U.S. pharma giant copyright scrapped two experimental weight loss tablets past yr—a when-daily capsule, lotiglipron, as a result of elevated liver enzymes plus a twice-each day pill, danuglipron, due to potent Unwanted effects—but CEO Albert Bourla has mentioned the company is determined to “Enjoy a